Orbapin 5 mg+20 mg (Tablet)
Unit Price: ৳ 12.00 (5 x 10: ৳ 600.00)
Strip Price: ৳ 120.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Amlodipine besilate olmesartan medoxomil |
| Company | Acme laboratories ltd |
| Also available as |
Title
Orbapin
Categories
- Medicine
- Antihypertensive
Description
Orbapin is indicated for the treatment of hypertension alone or with other antihypertensive agents, to lower blood pressure. It can be used as initial therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals. Orbapin is a combination of Amlodipine and Olmesartan Medoxomil that acts as a dihydropyridine calcium channel blocker and an angiotensin II receptor antagonist, respectively.
Indications
- Treatment of hypertension
- Initial therapy
- Blood pressure goals
Pharmacology
- Dihydropyridine calcium channel blocker
- Vasodilator
- ACE inhibitor
- Vasoconstrictor blocking effects
Dosage & Administration
- Initial therapy with 5/20 mg
- Titration
- Maximum dose of 10/40 mg
- Special dosing for elderly patients
Interaction
- Attenuation by NSAIDs
- Monitoring of blood pressure and renal function
Contraindications
- Co-administration with Aliskiren in diabetes patients
Side Effects
- Peripheral edema
- Headache
- Flushing
- Dizziness
- Sprue-like enteropathy
Pregnancy & Lactation
- Pregnancy Category D
- Fetal death risk
- Discontinuation during pregnancy
- Unknown excretion in human milk
Precautions & Warnings
- Risk of hypotension
- Vasodilation risk
- Increased angina or acute MI risk
- Use caution in special populations
Use in Special Populations
- Pediatric use not established
- No age-related differences
- No studies in renal impairment
- Initial therapy not recommended in hepatic impairment
Overdose Effects
- No human overdose information available
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of the reach of children